Advanced Therapy Medicinal Products Market size was valued at US$ 11.45 Bn in 2022 and the total revenue is expected to grow at 13.2 % through 2023 to 2029, reaching nearly US$ 27.29 Bn.Advanced Therapy Medicinal Products Market Overview:
Medical products in advanced treatment are progressive therapies that rely on high-quality treatment, extensive cell treatment, and tissue-constructed things. As a consequence, the worldwide advanced treatment medical goods market is projected to grow during the forecast period. ATMPs are pharmaceuticals that act on live cells or dynamic hereditary materials to provide innovative therapeutic options for a variety of infections, both acute and chronic.To know about the Research Methodology :- Request Free Sample Report
Advanced Therapy Medicinal Products Market Dynamics:
The introduction of Advanced Therapy Medicinal Products (ATMPs) has changed the pharmaceutical business and the panorama of medical treatment. It has laid the foundation for novel treatments for incurable illnesses and cancers of different kinds. The market is being driven by the success of products like Kymriah, Zolgensma, and others. The COVID-19 pandemic has driven a significant increase in the use of innovative treatments in virology research. T-cell therapy has the potential to cure high-risk COVID-19 infected patients, as mentioned in research published in December 2020. Before this, the FDA in the United States authorized ALVR109 (an allogeneic T-cell therapy IND application) for the treatment of COVID-19 patients in September 2020. This is likely to propel expenditure in advanced treatment research and development for SARS-CoV2 infections. Furthermore, an increasing number of clinical trials including Mesenchymal Stromal/Stem Cells (MSCs) have recently been filed as a novel therapy paradigm for SARS-CoV-2 infection. These treatments have exhibited encouraging outcomes in research programs as a therapeutic method, contributing to the marketspace's organic revenue creation. In recent years, the market for advanced treatment medical products has risen exponentially. The industry is expected to become more competitive as a growing number of businesses enter the market. Furthermore, new Advanced Therapy Medicinal Products (ATMP) approvals have boosted this sector's growth. Market participants are employing a variety of methods in order to maintain their market position. The current trend in this sector is collaborations with contract manufacturing firms. Due to increased Research and Development activity in this sector, contract manufacturing organizations (CMOs) are seeing a surge in demand for their services. Moreover, tie-up with Contract research organizations and contract manufacturing organizations are economical, licensed, and offer safety and security towards the end product. Hence, this factor is likely to motivate market growth in the future. Various protein and small molecule-based research & design firms have begun to focus on adoptive cell T treatments. For example, the U.S. FDA approved Bristol Myers Squibb's Abecma (idecabtagene vicleucel) - a cell-based gene therapy medicinal product designed for the treatment of patients with multiple myeloma - in March 2021, through a partnership with bluebird bio.Advanced Therapy Medicinal Products Market Segment Analysis:
The tissue-engineered product segment is anticipated to adhere to the growth of the Advanced Therapy Medicinal Products Market. In 2021, the tissue-engineered product category led the market, accounting for 39.0% of revenue. The adoption of tissue-engineered products or processes as an important element of medicine and treatment procedures, particularly in therapies that demand functional recovery of any sick or wounded area of the body, maybe ascribed to this dominance. The amount of publications, research papers, clinical trials, and translational products has increased dramatically in recent years, indicating that this area has gained substantial popularity. Furthermore, the segment's expansion is aided by ongoing advances in technology and products to advance the tissue engineering process. For example, a group of researchers at the University of Illinois Chicago presented a unique hydrogel-shaped-changing 4D material in February 2021 that can change form in response to physiological inputs. The CAR-T treatment sector, on the other hand, is getting popular in the market and is anticipated to grow at the strongest rate throughout the projection period. Key firms including Novartis AG, Gilead Sciences, Inc., and Bristol-Myers Squibb are emphasizing increasing the global reach of their CAR-T therapies. For example, Novartis AG revealed that the Health Sciences Authority has authorized Kymriah as Singapore's first commercially licensed CAR-T treatment. The growth is further supported by other segments such as cell therapy, and Gene therapyAdvanced Therapy Medicinal Products Market Regional Analysis:
North America is estimated to hit the market growth of the Advanced Therapy Medical Products Market in the coming future with 47% of revenue generation in the year 2021. The region's dominance in the market for advanced treatment medical goods is due to a favorable regulatory environment, successful product launches, and significant expenditures in research and development. In addition, the fast-growing majority of clinical investigations in this novel therapeutic method in the United States contribute to regional growth. In March 2021, the United States contributed around 57.0% of all the current immunotherapy trials worldwide. This high share implies that the market is seeing an increase in investment, which is driving revenue creation. Due to a robust research basis for innovative treatments, Europe held the second-largest share of the market in 2021. Further, the presence of prominent players in the regions is estimated to fuel the market growth in the forecast period. The objective of the report is to present a comprehensive analysis of the Global Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Advanced Therapy Medicinal Products Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Advanced Therapy Medicinal Products Market make the report investor’s guide.Advanced Therapy Medicinal Products Market Scope: Inquire before buying
Advanced Therapy Medicinal Products Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 11.45 Bn. Forecast Period 2022 to 2029 CAGR: 13.2% Market Size in 2029: US $ 27.29 Bn. Segments Covered: by Therapy Type • Cell Therapy o Stem Cell Therapy o Non-stem Cell Therapy • CAR-T Therapy • Gene Therapy • Tissue Engineered Product by Region • North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America) Advanced Therapy Medicinal Products Market Key Players
• Spark Therapeutics, Inc. • Bluebird Bio, Inc. • Novartis AG • UniQure N.V. • Celgene Corporation • Gilead Lifesciences, Inc. • Kolon TissueGene, Inc. • JCR Pharmaceuticals Co., Ltd. • MEDIPOST; • Vericel Corporation; • PHARMICELL Co., Ltd • Organogenesis Inc. • ViaCyte • Magenta Therapeutics • ReNeuron • Promethera Biosciences • Fate Therapeutics • Century TherapeuticsFAQs:
1. What is the global Advanced Therapy Medicinal Products Market value in 2022? Ans: The global Advanced Therapy Medicinal Products Market value in 2022 was estimated as 11.45 Billion USD. 2. What is the global Advanced Therapy Medicinal Products Market growth? Ans: The global Advanced Therapy Medicinal Products Market is anticipated to grow with a CAGR of 13.2% in the forecast period and is likely to reach USD 27.29 Billion by the end of 2029. 3. Which Therapy Type segment is expected to dominate the global Advanced Therapy Medicinal Products Market during the forecast period? Ans: The tissue-engineered product segment dominated the market with the largest revenue share of 39.0% in 2021. Owing to the incorporation of tissue-engineered products or procedures as an integral part of medicine and treatment procedures, particularly in treatments that require functional restoration of any diseased or injured part of the body 4. Which region is expected to dominate the global Advanced Therapy Medicinal Products Market during the forecast period? Ans: The North American region dominated the advanced therapy medicinal products market and accounted for the largest revenue share in 2022. 5. What is the key driving factor for the growth of the global Advanced Therapy Medicinal Products Market? Ans: Key factors driving the ATMPs market are the huge benefits of these therapies over conventional therapies, increasing investment to expand product portfolio, and ongoing notable M&A activities to mark entry in the space.
To know about the Research Methodology :- 1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Technology 2.3.2. Primary Research 2.3.2.1. Data from Primary Technology 2.3.2.2. Breakdown of Primary Technology 3. Executive Summary: Global Advanced Therapy Medicinal Products Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Advanced Therapy Medicinal Products Market 3.4. Geographical Snapshot of the Advanced Therapy Medicinal Products Market, By Manufacturer share 4. Global Advanced Therapy Medicinal Products Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Advanced Therapy Medicinal Products Market 5. Supply Side and Demand Side Indicators 6. Global Advanced Therapy Medicinal Products Market Analysis and Forecast, 2022-2029 6.1. Global Advanced Therapy Medicinal Products Market Size & Y-o-Y Growth Analysis. 7. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2022-2029 7.1.1. Cell Therapy 7.1.1.1. Stem Cell Therapy 7.1.1.2. Non-stem Cell Therapy 7.1.2. CAR-T Therapy 7.1.3. Gene Therapy 7.1.4. Tissue Engineered Product 8. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2022-2029 9.1.1. Cell Therapy 9.1.1.1. Stem Cell Therapy 9.1.1.2. Non-stem Cell Therapy 9.1.2. CAR-T Therapy 9.1.3. Gene Therapy 9.1.4. Tissue Engineered Product 10. North America Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 12. Canada Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 13. Mexico Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 14. Europe Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 15. Europe Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 17. France Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 18. Germany Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 19. Italy Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 20. Spain Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 21. Sweden Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 22. CIS Countries Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 23. Rest of Europe Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 24. Asia Pacific Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 25. Asia Pacific Advanced Therapy Medicinal Products Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 27. India Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 28. Japan Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 29. South Korea Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 30. Australia Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 31. ASEAN Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 32. Rest of Asia Pacific Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 33. Middle East Africa Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 34. Middle East Africa Advanced Therapy Medicinal Products Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 36. GCC Countries Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 37. Egypt Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 38. Nigeria Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 39. Rest of ME&A Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 40. South America Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 41. South America Advanced Therapy Medicinal Products Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 43. Argentina Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 44. Rest of South America Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Therapy Type’s, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Advanced Therapy Medicinal Products Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Biozeus Biopharmaceuticals. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Spark Therapeutics, Inc. 45.3.3. Bluebird Bio, Inc. 45.3.4. Novartis AG 45.3.5. UniQure N.V. 45.3.6. Celgene Corporation 45.3.7. Gilead Lifesciences, Inc. 45.3.8. Kolon TissueGene, Inc. 45.3.9. JCR Pharmaceuticals Co., Ltd. 45.3.10. MEDIPOST; 45.3.11. Vericel Corporation; 45.3.12. PHARMICELL Co., Ltd 45.3.13. Organogenesis Inc. 45.3.14. ViaCyte 45.3.15. Magenta Therapeutics 45.3.16. ReNeuron 45.3.17. Promethera Biosciences 45.3.18. Fate Therapeutics 45.3.19. Century Therapeutics Primary Key Insights